JEFFREY M LEIDEN
CIK 1242825 · Executive Chairman · last filed 2026-05-11
JEFFREY M LEIDEN is an Executive Chairman who has filed 121 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for ODTX, was dated May 11, 2026. Across all open-market trades the lifetime net is −$544.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $28.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$28.67M
4
121
-$544.74M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ODTX | Director | 298,896 | $26.39 | $7.89M | $100.0K | 1 | 2026-05-11 |
| VRTX | Executive Chairman | 35,237 | $548.05 | $19.31M | -$543.95M | 88 | 2026-02-26 |
| DGX | Director | 6,000 | $244.39 | $1.47M | -$890.2K | 15 | 2018-05-30 |
| MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted | Director | — | — | — | $0 | 2 | 2008-05-15 |
Recent Filings
121 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-11 | ODTX | Mixed | +36,644 | $99.7K | EDGAR |
| 2026-02-26 | VRTX | Tax (F) | −3,547 | -$1.72M | EDGAR |
| 2026-02-19 | VRTX | Mixed | +5,305 | -$1.43M | EDGAR |
| 2026-01-26 | VRTX | Grant (A) | +9,012 | $0 | EDGAR |
| 2025-12-05 | VRTX | Mixed | +1 | -$23.13M | EDGAR |
| 2025-12-03 | VRTX | Notice (144) | −63,781 | -$27.63M | EDGAR |
| 2025-11-17 | VRTX | Mixed | — | -$25.80M | EDGAR |
| 2025-11-14 | VRTX | Notice (144) | −53,604 | -$23.29M | EDGAR |
| 2025-11-13 | VRTX | Notice (144) | −19,688 | -$8.55M | EDGAR |
| 2025-02-19 | VRTX | Tax (F) | −6,066 | -$2.81M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.